Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Momentum

Simply Wall St.01-08

With no single headline event setting the tone, Amphastar Pharmaceuticals (AMPH) draws attention through its recent trading pattern, including a 3.4% move over the past week and a last close of $27.62...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2601733683?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","is_english":true,"pubTime":"2026-01-08 06:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601733683","market":"sg","top_or_hot":-1,"title":"Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Momentum","media":"Simply Wall St.","content":"<div>\n<p>With no single headline event setting the tone, Amphastar Pharmaceuticals (AMPH) draws attention through its recent trading pattern, including a 3.4% move over the past week and a last close of $27.62...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amph/amphastar-pharmaceuticals/news/assessing-amphastar-pharmaceuticals-amph-valuation-after-rec-1\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Momentum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Momentum\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-08 06:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amph/amphastar-pharmaceuticals/news/assessing-amphastar-pharmaceuticals-amph-valuation-after-rec-1><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With no single headline event setting the tone, Amphastar Pharmaceuticals (AMPH) draws attention through its recent trading pattern, including a 3.4% move over the past week and a last close of $27.62...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amph/amphastar-pharmaceuticals/news/assessing-amphastar-pharmaceuticals-amph-valuation-after-rec-1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amph/amphastar-pharmaceuticals/news/assessing-amphastar-pharmaceuticals-amph-valuation-after-rec-1","article_id":"2601733683","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amph/amphastar-pharmaceuticals/news/assessing-amphastar-pharmaceuticals-amph-valuation-after-rec-1","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2601733683","pubTimestamp":1767824175,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"With no single headline event setting the tone, Amphastar Pharmaceuticals (AMPH) draws attention through its recent trading pattern, including a 3.4% move over the past week and a last close of $27.62.\nSee our latest analysis for Amphastar Pharmaceuticals.\nThat recent 1-day share price return of 3.37% and 7-day share price return of 2.30% comes on top of a 90-day share price return of 6.31%. The 1-year total shareholder return of a 21.65% decline contrasts with a 41.50% total shareholder...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","AMPH":"Amphastar Pharmaceuticals","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4557":"大麻股"},"translate_title":"在近期股价势头后评估Amphastar Pharmaceuticals(AMPH)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMPH":1.5},"content_text":"With no single headline event setting the tone, Amphastar Pharmaceuticals (AMPH) draws attention through its recent trading pattern, including a 3.4% move over the past week and a last close of $27.62. See our latest analysis for Amphastar Pharmaceuticals. That recent 1-day share price return of 3.37% and 7-day share price return of 2.30% comes on top of a 90-day share price return of 6.31%. The 1-year total shareholder return of a 21.65% decline contrasts with a 41.50% total shareholder return over five years, suggesting short term momentum is picking up even as longer term holders have experienced a mixed journey. If Amphastar’s move has you thinking more broadly about healthcare, this could be a good moment to scan opportunities across healthcare stocks and see what else stands out on your watchlist. With Amphastar posting steady recent returns and trading around $27.62, the key question is whether the current price understates its earnings power, or if the market is already pricing in its future growth potential? AdvertisementMost Popular Narrative Narrative: 13.7% Undervalued Compared with the last close at $27.62, the most followed narrative points to a higher fair value, setting up a clear valuation gap to unpack. While Amphastar is investing in capacity expansion and proprietary pipeline products, rising R&D and capital expenditures (up 14% YoY) could weigh on profitability, especially if new product launches in crowded or commoditized segments (like GLP-1s) result in only modest incremental revenues. Read the complete narrative. Want to see what sits behind this valuation gap? The narrative leans heavily on moderate revenue growth, slightly thinner margins, and a future earnings multiple below the wider pharma group. Curious how those pieces fit together? Result: Fair Value of $32 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there is still a chance that a stronger pipeline than expected or faster uptake of products like BAQSIMI could support higher earnings than this narrative assumes. Find out about the key risks to this Amphastar Pharmaceuticals narrative.  Build Your Own Amphastar Pharmaceuticals Narrative If you see the numbers differently or prefer to test your own assumptions, you can build a tailored Amphastar view in just a few minutes, starting with Do it your way. A great starting point for your Amphastar Pharmaceuticals research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? If Amphastar is already on your radar, do not stop there. Widen your search and let a few focused stock lists spark fresh ideas for your shortlist.  Hunt for potential value by scanning these 876 undervalued stocks based on cash flows that might offer pricing that does not fully reflect their underlying cash flows. Spot potential income ideas through these 11 dividend stocks with yields > 3% that combine yield with business fundamentals you can investigate further. Get ahead of emerging themes by checking out these 79 cryptocurrency and blockchain stocks tied to blockchain, digital assets, and payment infrastructure trends.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601733683","isCrawlerRequest":true}